Jazz Pharma director to sell 2,691 shares
Jazz Pharmaceuticals plc (JAZZ) reports that director Mary Elizabeth Henderson has filed a notice of proposed sale of 2,691 shares of common stock under Rule 144.
Rhea-AI Filing Summary
Jazz Pharmaceuticals plc (JAZZ) reports that director Mary Elizabeth Henderson has filed a notice of proposed sale of 2,691 shares of common stock under Rule 144. A prior sale during the last three months involved 2,092 common shares with a reported transaction amount of 504,898.00.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 2,691 shares
Shares sold in past three months: 2,092 shares
Reported amount for prior sale: 504,898.00
+2 more
5 metrics
Shares proposed to be sold
2,691 shares
Common stock of Jazz Pharmaceuticals plc under Rule 144
Shares sold in past three months
2,092 shares
Sale on August 31, 2026 by Mary Elizabeth Henderson
Reported amount for prior sale
504,898.00
Transaction amount linked to 2,092-share sale on August 31, 2026
Planned sale date reference
September 8, 2026
Date shown in connection with the proposed sale information
Issuer phone number
353-1-634-7800
Contact number for Jazz Pharmaceuticals plc
Key Terms
Rule 144, restricted stock vesting, power of attorney
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"COMMON | 09/05/2026 | RESTRICTED STOCK VESTING | ISSUER"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
power of attorney regulatory
"Signature | /s/Paz Dizon by power of attorney for Mary Elizabeth Henderson"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
What does the Form 144 filing disclose for JAZZ?
It discloses that director Mary Elizabeth Henderson has filed a notice under Rule 144 to sell 2,691 shares of Jazz Pharmaceuticals plc common stock, and that she reported a prior sale of 2,092 shares within the preceding three months.
Which broker is listed for the JAZZ Form 144 transaction?
The broker listed in connection with the Jazz Pharmaceuticals plc common stock is E*TRADE Financial Corporation, with an address at 3 Edison Drive, Alpharetta, Georgia.
What security class is involved in the JAZZ Form 144 filing?
The Form 144 relates to common stock of Jazz Pharmaceuticals plc, identified in the filing as the security to be sold and as the class previously sold within the past three months.
Who signed the JAZZ Form 144 notice?
The notice is signed as “/s/ Paz Dizon by power of attorney for Mary Elizabeth Henderson”, indicating execution under a power of attorney on behalf of Mary Elizabeth Henderson.
AI-generated analysis. How Rhea-AI works. Not financial advice.